Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Sideways curvature of the spine (scoliosis), Flexion contracture, Muscle fiber intracytoplasmic reducing inclusion bodies, and Difficulty running and others; and common findings: Enlarged and weakened heart (dilated cardiomyopathy). 16 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 6 | Flexion contracture, Muscle fiber intracytoplasmic reducing inclusion bodies, Difficulty breathing due to muscle weakness (respiratory insufficiency due to muscle weakness) |
FHL1 encodes four and a half LIM domains 1 (323 aa). May have an involvement in muscle development or hypertrophy Highest expression in Muscle Skeletal (2,025 TPM) and Artery Tibial (1,151 TPM).
Myopathy, reducing body, X-linked, childhood-onset is associated with mutations in the FHL1 gene on chromosome X.
The FHL1 protein participates in Complement cascade pathway.
FHL1 is classified as a druggable target with score 17.4.
Genetic testing for FHL1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for myopathy, reducing body, X-linked, childhood-onset has been reported in the published literature.
Phenotype severity distribution: 8 always present features, 1 common feature.
No clinical trials have been registered for myopathy, reducing body, X-linked, childhood-onset.
156 publications have been identified in PubMed for myopathy, reducing body, X-linked, childhood-onset. Research spans Epidemiology / Natural History (68%), Review / Meta-Analysis (11%), and Basic Science / Preclinical (9%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 106 | 68% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:36 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints | 3 | Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis), Excessive inward curvature of the lower spine (hyperlordosis) |
Brain and nerves | 2 | Hyporeflexia, Spinal rigidity |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Lungs and breathing | 1 | Difficulty breathing due to muscle weakness (respiratory insufficiency due to muscle weakness) |
Heart and blood vessels | 1 | Enlarged and weakened heart (dilated cardiomyopathy) |
Research summaries |
17 |
11% |
Laboratory research | 14 | 9% |
Patient case studies | 6 | 4% |
Clinical study results | 5 | 3% |
Other research | 4 | 3% |
Testing and diagnosis research | 3 | 2% |
New treatment approaches | 1 | 1% |
Ahtinen K (2026). [PMID: 41504984](https://pubmed.ncbi.nlm.nih.gov/41504984/). *Neurol Sci*. [Epidemiology / Natural History]
Fava D (2026). [PMID: 41521526](https://pubmed.ncbi.nlm.nih.gov/41521526/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Buja A (2026). [PMID: 40818023](https://pubmed.ncbi.nlm.nih.gov/40818023/). *International journal of cancer*. [Epidemiology / Natural History]
Hilbert J (2026). [PMID: 41579288](https://pubmed.ncbi.nlm.nih.gov/41579288/). *Eur J Epidemiol*. [Review / Meta-Analysis]
Zhou X (2026). [PMID: 40956048](https://pubmed.ncbi.nlm.nih.gov/40956048/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Epidemiology / Natural History]
Kong Y (2026). [PMID: 41058269](https://pubmed.ncbi.nlm.nih.gov/41058269/). *Ann Clin Transl Neurol*. [Epidemiology / Natural History]
Macaron G (2026). [PMID: 41925503](https://pubmed.ncbi.nlm.nih.gov/41925503/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]
Bertrand F (2026). [PMID: 42112640](https://pubmed.ncbi.nlm.nih.gov/42112640/). *Geriatr Psychol Neuropsychiatr Vieil*. [Review / Meta-Analysis]
Ellenberger D (2026). [PMID: 40921616](https://pubmed.ncbi.nlm.nih.gov/40921616/). *J Neurol Neurosurg Psychiatry*. [Epidemiology / Natural History]
Velucci V (2026). [PMID: 41353805](https://pubmed.ncbi.nlm.nih.gov/41353805/). *Journal of the neurological sciences*. [Epidemiology / Natural History]